Skip to main content
. Author manuscript; available in PMC: 2012 Jul 1.
Published in final edited form as: Cancer Prev Res (Phila). 2011 May 10;4(7):1061–1072. doi: 10.1158/1940-6207.CAPR-11-0006

Table 3.

Kappa statistic (κ) of inter-classification agreement, 95% confidence intervals, and agreement percentage between sample classification by promoter methylation of HOXA9 and NID2 and by histology on head and neck cancer saliva samples. (n=51)

Variable Kappa coefficient
κ (95% CI) Percentage
agreement
(%)
Oral and oropharyngeal cancer
HOXA9 0.52 (−0.12, 0.42) 59
NID2 0.55 (−0.18, 0.37) 59
Oral cancer
HOXA9 0.21 (−0.11, 0.52) 60
NID2 0.23 (−0.03, 0.49) 60